Pictet-Biotech P dy/ LU0320646986 /
| NAV2/7/2023 | Chg.-4.9900 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 667.3700GBP | -0.74% | paying dividend | Equity Worldwide | Pictet AM (EU) ▶ |
- Dividends adjusted Dividends adjusted
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2007 | - | - | - | - | - | - | - | - | - | - | - | -2.19 | - |
| 2008 | -3.05 | -2.76 | 1.06 | 3.15 | 2.78 | -1.68 | 15.82 | 4.24 | -4.52 | -5.73 | -5.51 | 16.29 | +18.59% |
| 2009 | 1.61 | -8.90 | 3.14 | -10.38 | -6.25 | 5.08 | 4.96 | -1.02 | 6.84 | -13.76 | 4.55 | 4.78 | -11.60% |
| 2010 | 2.33 | 4.53 | 5.59 | -0.71 | -9.39 | -8.68 | 1.03 | -0.88 | 8.11 | 1.54 | 0.04 | 9.11 | +11.34% |
| 2011 | -3.24 | -0.24 | 5.47 | 1.00 | 0.56 | 0.08 | -4.91 | -11.29 | -1.48 | 4.01 | 3.05 | 1.54 | -6.41% |
| 2012 | 7.57 | -1.53 | 5.04 | 0.43 | 4.49 | 6.47 | 1.73 | -1.36 | 2.91 | -7.57 | 5.02 | -2.98 | +20.89% |
| 2013 | 10.16 | 5.00 | 7.47 | 3.96 | 5.50 | -4.27 | 12.18 | -2.11 | 3.78 | -4.23 | 5.38 | 0.89 | +51.42% |
| 2014 | 10.04 | 5.05 | -9.71 | -8.23 | 2.25 | 5.77 | -1.06 | 9.83 | 0.68 | 9.69 | 4.80 | 0.32 | +30.73% |
| 2015 | 10.49 | 2.39 | 5.81 | -8.16 | 11.89 | -1.19 | 3.94 | -8.48 | -8.90 | 2.93 | 5.67 | 2.18 | +17.07% |
| 2016 | -19.19 | -4.60 | 1.04 | 1.15 | 4.90 | 0.45 | 13.10 | -3.24 | 2.76 | -5.07 | 4.87 | -2.46 | -9.33% |
| 2017 | 4.85 | 8.35 | -1.34 | -1.51 | -4.06 | 8.71 | 1.21 | 7.22 | -4.01 | -5.77 | -2.10 | 2.69 | +13.60% |
| 2018 | 1.55 | -2.16 | -3.93 | -1.80 | 7.88 | 2.19 | 4.39 | 4.84 | -1.79 | -12.01 | 2.53 | -10.21 | -10.02% |
| 2019 | 12.15 | 2.85 | 1.12 | -3.88 | -0.61 | 7.53 | 4.37 | -5.50 | -6.43 | 2.92 | 13.57 | -1.90 | +26.77% |
| 2020 | -3.72 | 0.10 | -0.94 | 16.50 | 6.69 | 2.40 | -7.59 | -0.91 | 9.77 | -4.00 | 3.65 | 1.83 | +23.76% |
| 2021 | 3.29 | -4.50 | -2.89 | 1.05 | -6.51 | 6.69 | -2.59 | 5.90 | -1.05 | -4.11 | -3.45 | 1.32 | -7.56% |
| 2022 | -18.01 | -2.23 | 5.87 | -5.68 | -4.23 | 8.46 | 6.82 | 9.01 | 2.22 | -1.07 | 0.11 | -3.40 | -5.32% |
| 2023 | 0.69 | 1.81 | - | - | - | - | - | - | - | - | - | - | - |
Single months: Dividends not considered
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 18.64% | 23.83% | 29.30% | 26.53% | 24.90% |
| Sharpe ratio | 1.45 | -0.38 | 0.42 | -0.01 | 0.09 |
| Best month | +1.81% | +9.01% | +9.01% | +16.50% | +16.50% |
| Worst month | -3.40% | -3.40% | -5.68% | -18.01% | -18.01% |
| Maximum loss | -3.77% | -9.95% | -18.58% | -39.23% | -39.23% |
| Outperformance | -0.31% | - | -4.89% | -2.85% | -8.68% |
All quotes in GBP
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Pictet-Biotech I | reinvestment | 892.0600 | +9.85% | +4.20% | |
| Pictet-Biotech HI | reinvestment | 533.8100 | -0.80% | -4.78% | |
| Pictet-Biotech I dy | paying dividend | 795.5300 | +15.85% | +9.70% | |
| Pictet-Biotech Z | reinvestment | 1,060.8000 | +3.61% | +4.47% | |
| Pictet-Biotech I | reinvestment | 952.4000 | +2.60% | +1.42% | |
| Pictet-Biotech P dy | paying dividend | 799.4500 | +1.68% | -1.23% | |
| Pictet-Biotech R | reinvestment | 691.5900 | +0.98% | -3.28% | |
| Pictet-Biotech R | reinvestment | 647.3700 | +8.11% | -0.67% | |
| Pictet-Biotech P dy | paying dividend | 667.3700 | +14.82% | +6.78% | |
| Pictet-Biotech HP | reinvestment | 609.2200 | -1.89% | -7.88% | |
| Pictet-Biotech HP | reinvestment | 501.6600 | -1.69% | -7.32% | |
| Pictet-Biotech P | reinvestment | 748.7300 | +8.87% | +1.43% | |
| Pictet-Biotech HR | reinvestment | 433.7300 | -2.38% | -9.25% | |
| Pictet-Biotech P | reinvestment | 799.7400 | +1.68% | -1.23% |
Performance
| YTD | +2.51% | ||
|---|---|---|---|
| 6 Months | -3.27% | ||
| 1 Year | +14.82% | ||
| 3 Years | +6.78% | ||
| 5 Years | +27.06% | ||
| 10 Years | +171.22% | ||
| Since start | +296.82% | ||
| Year | |||
| 2022 | -5.32% | ||
| 2021 | -7.56% | ||
| 2020 | +23.76% | ||
| 2019 | +26.77% | ||
| 2018 | -10.02% | ||
| 2017 | +13.60% | ||
| 2016 | -9.33% | ||
| 2015 | +17.07% | ||
| 2014 | +30.73% | ||